JANONE INC (JAN)

US47089W1045 - Common Stock

4  +0.1 (+2.56%)

Fundamental Rating

1

JAN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 85 industry peers in the Commercial Services & Supplies industry. JAN has a bad profitability rating. Also its financial health evaluation is rather negative. JAN has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year JAN has reported negative net income.
In the past year JAN had a positive cash flow from operations.
In the past 5 years JAN reported 4 times negative net income.
In the past 5 years JAN reported 4 times negative operating cash flow.

1.2 Ratios

JAN has a Return On Assets of -42.24%. This is amonst the worse of the industry: JAN underperforms 89.16% of its industry peers.
The Return On Equity of JAN (-69.71%) is worse than 79.52% of its industry peers.
Industry RankSector Rank
ROA -42.24%
ROE -69.71%
ROIC N/A
ROA(3y)-43.38%
ROA(5y)-41.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

JAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JAN has been increased compared to 1 year ago.
The number of shares outstanding for JAN has been increased compared to 5 years ago.
Compared to 1 year ago, JAN has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -2.28, we must say that JAN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.28, JAN is doing worse than 86.75% of the companies in the same industry.
The Debt to FCF ratio of JAN is 0.48, which is an excellent value as it means it would take JAN, only 0.48 years of fcf income to pay off all of its debts.
JAN has a Debt to FCF ratio of 0.48. This is amongst the best in the industry. JAN outperforms 86.75% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that JAN is not too dependend on debt financing.
JAN has a Debt to Equity ratio of 0.06. This is in the better half of the industry: JAN outperforms 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.48
Altman-Z -2.28
ROIC/WACCN/A
WACC9.65%

2.3 Liquidity

JAN has a Current Ratio of 0.06. This is a bad value and indicates that JAN is not financially healthy enough and could expect problems in meeting its short term obligations.
JAN has a Current ratio of 0.06. This is amonst the worse of the industry: JAN underperforms 98.80% of its industry peers.
JAN has a Quick Ratio of 0.06. This is a bad value and indicates that JAN is not financially healthy enough and could expect problems in meeting its short term obligations.
JAN has a Quick ratio of 0.06. This is amonst the worse of the industry: JAN underperforms 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06

0

3. Growth

3.1 Past

JAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.65%.
Looking at the last year, JAN shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-113.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-477.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

JAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

67.47% of the companies in the same industry are more expensive than JAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.49
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JANONE INC

NASDAQ:JAN (5/6/2024, 1:24:04 PM)

4

+0.1 (+2.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap34.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.24%
ROE -69.71%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-113.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y